{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:26:00Z","timestamp":1787757960491,"version":"build-2784847793"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:p>A 77-year-old male patient developed acrocyanosis and pain after treatment with amphotericin B liposome 150 mg daily intravenously for disseminated histoplasmosis, and subsequently developed elevated serum creatinine. Amphotericin B liposome was discontinued, and anisodamine was used intravenously to treat acrocyanosis and pain induced by amphotericin B liposome for 9 days and patient was cured. Naranjo adverse drug reaction probability scale score was 5, the World Health Organization-Uppsala Monitoring Centre criteria: Probable, indicating a probable adverse reaction to amphotericin B liposome.<\/jats:p>","DOI":"10.4103\/0253-7613.182889","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T06:41:01Z","timestamp":1465800061000},"page":"321-323","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Amphotericin B liposome-induced acrocyanosis and elevated serum creatinine"],"prefix":"10.4103","volume":"48","author":[{"given":"Xiangcai","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Hangzhou Red Cross Hospital, Hangzhou 310003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hangzhou Red Cross Hospital, Hangzhou 310003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Respiration, Hangzhou Red Cross Hospital, Hangzhou 310003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hangzhou Red Cross Hospital, Hangzhou 310003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hangzhou Red Cross Hospital, Hangzhou 310003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hangzhou Red Cross Hospital, Hangzhou 310003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260605","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","article-title":"Amphotericin B formulations: A comparative review of efficacy and toxicity","volume":"73","author":"Hamill","year":"2013","journal-title":"Drugs"},{"key":"R2-20260605","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1365-3156.2008.02128.x","article-title":"Safety of a pre-formulated amphotericin B lipid emulsion for the treatment of Indian Kala-azar","volume":"13","author":"Sundar","year":"2008","journal-title":"Trop Med Int Health"},{"key":"R4-20260605","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R5-20260605","first-page":"2229","article-title":"Preventability and severity assessment in reporting adverse drug reactions","volume":"49","author":"Hartwig","year":"1992","journal-title":"Am J Hosp Pharm"},{"key":"R6-20260605","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-3-642-00663-0_5","article-title":"Mechanisms of drug-induced nephrotoxicity","volume":"196","author":"Nolin","year":"2010","journal-title":"Handb Exp Pharmacol"},{"key":"R7-20260605","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1439-0507.1997.tb00250.x","article-title":"Cyanotic Raynaud's phenomenon with conventional but not with liposomal amphotericin B: Three case reports","volume":"40","author":"Zernikow","year":"1997","journal-title":"Mycoses"},{"key":"R8-20260605","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1439-0507.2007.01360.x","article-title":"Acrocyanosis developed with amphotericin B deoxycholate but not with amphotericin B lipid complex","volume":"50","author":"Ozaras","year":"2007","journal-title":"Mycoses"},{"key":"R9-20260605","first-page":"136","article-title":"New choice for the treatment of Raynaud's symptoms: A type botulinum toxin","volume":"19","author":"Hongmei","year":"2015","journal-title":"Chin J Rheumatol"},{"issue":"Suppl 1","key":"R10-20260605","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/49.suppl_1.37","article-title":"Amphotericin B nephrotoxicity","volume":"49","author":"Deray","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"R11-20260605","first-page":"77","article-title":"Raynaud's phenomenon","volume":"56","author":"Zeni","year":"2004","journal-title":"Reumatismo"},{"key":"R12-20260605","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.08.2011.4621","article-title":"Buerger's disease (Thromboangiitis obliterans): A diagnostic challenge","author":"Jorge","year":"2011","journal-title":"BMJ Case Rep 2011"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363791-201648030-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:00:11Z","timestamp":1787756411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363791-201648030-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4103\/0253-7613.182889","relation":{},"ISSN":["0253-7613","1998-3751"],"issn-type":[{"value":"0253-7613","type":"print"},{"value":"1998-3751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"2016-02-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-05-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}